Tag: atrial fibrillation market forecast

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Are the Projected Market Size and Growth Rates for the Atrial Fibrillation Market From 2025 To 2029?#_x000D_

There’s been a swift expansion in the size of the atrial fibrillation market in the previous years. Starting from $13.56 billion in 2024, it is projected to escalate to $15.1 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 11.4%. The surge during the historical phase can be credited to a rise in awareness and screening initiatives, technology advancements in treatments, a hike in healthcare spending, clinical investigations, and medicinal development, along with genetic inclination._x000D_

_x000D_

In the coming years, the atrial fibrillation market size is predicted to experience a swift surge in growth, expanding to$24.72 billion by 2029 with a compound annual growth rate (CAGR) of 13.1%. The expected growth within the forecast period can be ascribed to concentrated efforts on stroke prevention, extensive patient and physician education initiatives, worldwide actions for cardiovascular wellbeing, an increase in electrophysiology processes, personalized treatment designs, and government-led initiatives aimed at preventing cardiovascular diseases. Significant trends for the forecast period contain progress in diagnostic technologies, increased occurrence of atrial fibrillation, advancements in catheter ablation methods, the introduction of novel oral anticoagulants (NOACs), the inclusion of wearable technologies for monitoring purposes, a growing emphasis on telemedicine in managing AF, and advancements in implantable devices._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp_x000D_

_x000D_

#What are the Fundamental Drivers and Innovations Shaping the Atrial Fibrillation Market?#_x000D_

The rise in the number of older adults is projected to propel the atrial fibrillation market. The term geriatric population alludes to adults aged 65 and beyond, who are prone to falls due to a variety of reasons, including postural hypotension and issues with balance or gait. In most elderly patients, age-related factors and conduction irregularities appear on the surface electrocardiogram before the onset of atrial fibrillation. For example, the World Health Organization, a Switzerland-based branch of the United Nations tasked with global public health, stated in October 2022 that by 2030, six people out of ten will be 60 years old or more. This means the population of people over 60 will increase to 1.4 billion, a significant increment from 1 billion in 2020. The global population of those aged 60 and above is set to double to 2.1 billion by 2050. Furthermore, between 2020 and 2050, there will be an additional 426 million people aged 80 or more than the current figures. Therefore, the escalating geriatric population is a significant contributor to the growth of the atrial fibrillation market._x000D_

_x000D_

#How Is the Atrial Fibrillation Market Segmented?#_x000D_

The atrial fibrillationmarket covered in this report is segmented – _x000D_

_x000D_

1) By Type: Surgical; Non-Surgical_x000D_

2) By Technology: Radiofrequency; Laser; Cryotherapy; Other Technologies_x000D_

3) By Treatment Type: Pharmacological Treatment; Non-pharmacological Treatment; Maze Surgery; Electric Cardioversion_x000D_

4) By End User: Hospitals; Electrophysiology Labs; Ambulatory Surgical Centers_x000D_

_x000D_

Subsegments:_x000D_

1) By Surgical: Catheter Ablation; Maze Procedure; Hybrid Ablation Procedures _x000D_

2) By Non-Surgical: Antiarrhythmic Drugs; Anticoagulants; Cardioversion Procedures; Device Implants _x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=8007&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Atrial Fibrillation Market Growth?#_x000D_

North America was the largest region in the atrial fibrillation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Trends Are Shaping the Future of the Atrial Fibrillation Market?#_x000D_

Leading organizations in the atrial fibrillation market are focusing on product innovation, including the development of patient-focused clinical decision support tools to bolster their market standing. Clinical decision support tools (CDST), typically software or electronic systems, serve as aid to healthcare professionals for making informed, timely decisions about patient care by collating vital clinical data from various sources. For example, GE HealthCare, a multinational medical technology firm based in the US, launched CardioVisio in August 2023. This patient-centric clinical decision support tool was designed to give doctors access to evidence-based clinical decision support in line with current atrial fibrillation guidelines, while also offering a visualization of longitudinal data pertinent to disease progression from many different sources. CardioVisio for atrial fibrillation allows cardiologists streamline clinician image interpretation and gain an overview of the patient’s heart history and healthcare journey, comprising previous diagnoses, prescribed treatments, procedures, and associated diseases._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report_x000D_

_x000D_

#How Is the Atrial Fibrillation Market Defined and What Are Its Core Parameters?#_x000D_

Atrial fibrillation refers to a disorder of the heart caused by an abnormality in the normal sequence of electrical impulses that changes the rate or rhythm at which the heart beats and begins in the heart’s upper chambers (atria). Electrical impulses can be too fast, too slow, or erratically occurring, resulting in irregular heartbeats._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8007_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Atrial Fibrillation Market From 2025 To 2029?

There’s been a swift expansion in the size of the atrial fibrillation market in the previous years. Starting from $13.56 billion in 2024, it is projected to escalate to $15.1 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 11.4%. The surge during the historical phase can be credited to a rise in awareness and screening initiatives, technology advancements in treatments, a hike in healthcare spending, clinical investigations, and medicinal development, along with genetic inclination.

In the coming years, the atrial fibrillation market size is predicted to experience a swift surge in growth, expanding to$24.72 billion by 2029 with a compound annual growth rate (CAGR) of 13.1%. The expected growth within the forecast period can be ascribed to concentrated efforts on stroke prevention, extensive patient and physician education initiatives, worldwide actions for cardiovascular wellbeing, an increase in electrophysiology processes, personalized treatment designs, and government-led initiatives aimed at preventing cardiovascular diseases. Significant trends for the forecast period contain progress in diagnostic technologies, increased occurrence of atrial fibrillation, advancements in catheter ablation methods, the introduction of novel oral anticoagulants (NOACs), the inclusion of wearable technologies for monitoring purposes, a growing emphasis on telemedicine in managing AF, and advancements in implantable devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

What are the Fundamental Drivers and Innovations Shaping the Atrial Fibrillation Market?

The rise in the number of older adults is projected to propel the atrial fibrillation market. The term geriatric population alludes to adults aged 65 and beyond, who are prone to falls due to a variety of reasons, including postural hypotension and issues with balance or gait. In most elderly patients, age-related factors and conduction irregularities appear on the surface electrocardiogram before the onset of atrial fibrillation. For example, the World Health Organization, a Switzerland-based branch of the United Nations tasked with global public health, stated in October 2022 that by 2030, six people out of ten will be 60 years old or more. This means the population of people over 60 will increase to 1.4 billion, a significant increment from 1 billion in 2020. The global population of those aged 60 and above is set to double to 2.1 billion by 2050. Furthermore, between 2020 and 2050, there will be an additional 426 million people aged 80 or more than the current figures. Therefore, the escalating geriatric population is a significant contributor to the growth of the atrial fibrillation market.

How Is the Atrial Fibrillation Market Segmented?

The atrial fibrillationmarket covered in this report is segmented –

1) By Type: Surgical; Non-Surgical

2) By Technology: Radiofrequency; Laser; Cryotherapy; Other Technologies

3) By Treatment Type: Pharmacological Treatment; Non-pharmacological Treatment; Maze Surgery; Electric Cardioversion

4) By End User: Hospitals; Electrophysiology Labs; Ambulatory Surgical Centers

Subsegments:

1) By Surgical: Catheter Ablation; Maze Procedure; Hybrid Ablation Procedures

2) By Non-Surgical: Antiarrhythmic Drugs; Anticoagulants; Cardioversion Procedures; Device Implants

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8007&type=smp

Which Regions Are Driving the Next Phase of the Atrial Fibrillation Market Growth?

North America was the largest region in the atrial fibrillation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Atrial Fibrillation Market?

Leading organizations in the atrial fibrillation market are focusing on product innovation, including the development of patient-focused clinical decision support tools to bolster their market standing. Clinical decision support tools (CDST), typically software or electronic systems, serve as aid to healthcare professionals for making informed, timely decisions about patient care by collating vital clinical data from various sources. For example, GE HealthCare, a multinational medical technology firm based in the US, launched CardioVisio in August 2023. This patient-centric clinical decision support tool was designed to give doctors access to evidence-based clinical decision support in line with current atrial fibrillation guidelines, while also offering a visualization of longitudinal data pertinent to disease progression from many different sources. CardioVisio for atrial fibrillation allows cardiologists streamline clinician image interpretation and gain an overview of the patient’s heart history and healthcare journey, comprising previous diagnoses, prescribed treatments, procedures, and associated diseases.

View the full report here:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

How Is the Atrial Fibrillation Market Defined and What Are Its Core Parameters?

Atrial fibrillation refers to a disorder of the heart caused by an abnormality in the normal sequence of electrical impulses that changes the rate or rhythm at which the heart beats and begins in the heart’s upper chambers (atria). Electrical impulses can be too fast, too slow, or erratically occurring, resulting in irregular heartbeats.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8007

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Atrial Fibrillation Market Grown from 2024 to 2025?

Rapid expansion has been experienced in the size of the atrial fibrillation market in the past few years. The market size is projected to increase from $13.56 billion in 2024 to $15.14 billion in 2025, with a compound annual growth rate (CAGR) of 11.7%. The historic growth can be credited to factors such as heightened awareness and screening programs, technological advances in treatment, an upsurge in healthcare spending, clinical studies and drug development, and genetic susceptibility.

What Growth Rate Is Anticipated for the Atrial Fibrillation Market in the Coming Years?

The market size for atrial fibrillation is projected to experience a swift expansion in the forthcoming years, estimated to reach up to $24.93 billion by 2029 with a compound annual growth rate (CAGR) of 13.3%. The projected growth within this period can be ascribed to the increased emphasis on stroke prevention, educational activities about the condition for patients and doctors, worldwide initiatives for cardiovascular health, an upsurge in electrophysiology procedures, personalization of treatment plans, and government-led initiatives targeting prevention of cardiovascular disease. Factors trending within this forecast period that could greatly shape the expansion include improved diagnostic technologies, a surge in atrial fibrillation incidents, progress in catheter ablation methods, the development of novel oral anticoagulants (NOACs), the incorporation of wearable technology for patient monitoring, the enlarging scope of telemedicine in atrial fibrillation management, and continued progress in implantable devices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

Who Are the Leading Companies in the Atrial Fibrillation Market?

Major companies operating in the atrial fibrillation market are AtriCure Inc., Johnson & Johnson Private Limited, Abbott Laboratories, C.H. Boehringer Sohn AG & Co. KG, Biotronik Se & Co. Kg, Boston Scientific Corporation, Bristol-Myers Squibb Company, CardioFocus Inc., Sanofi S.A, Medtronic PLC, Biosense Webster Inc., MicroPort Scientific Corporation, Siemens AG, Acutus Medical Inc., AEGEA Medical Inc., Apama Medical Inc., Aria CV Inc., Armetheon Inc., BioSig Technologies Inc., Cardialen Inc., CardioRobotics Inc., CardioInsight Technologies Inc., Circa Scientific LLC, CorWave SA, EpiEP Inc., Farapulse Inc., Fibralign Corporation, Impulse Dynamics NV, JenaValve Technology Inc., Kardium Inc.

What Are the Key Drivers of the Atrial Fibrillation Market?

The aging population is projected to propel the atrial fibrillation market. Senior citizens, aged 65 and above, are more prone to afflictions like postural hypotension and issues related to balance or gait, increasing their chances of falling. Most of these elderly patients display age-related and conduction disturbances on their surface electrocardiogram before the onset of atrial fibrillation. For example, the World Health Organization, a Switzerland-based United Nations agency specializing in international public health, reported in October 2022 that by 2030, the world’s elderly population (60 years and above) would reach six. By then, the number of this demographic will increase from 1 billion in 2020 to 1.4 billion. Furthermore, by 2050, the count of people aged 60 and above will practically double, reaching 2.1 billion. From 2020 to 2050, there will be an additional 426 million individuals aged 80 and above compared to the current count. Thus, the expanding elderly population is triggering the atrial fibrillation market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8007&type=smp

What Are the Key Market Segments in the Atrial Fibrillation Industry?

The atrial fibrillation market covered in this report is segmented –

1) By Type: Surgical, Non-Surgical

2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies

3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion

4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Subsegments:

1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures

2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures, Device Implants

What Are the Latest Trends in the Atrial Fibrillation Market?

Leading businesses in the atrial fibrillation market, such as GE HealthCare, are introducing cutting-edge products and solutions, like patient-centric clinical decision support tools, to bolster their market presence. Clinical decision support tools (CDST) are essentially software or digital systems created to support healthcare practitioners in making timely and informed decisions regarding patient treatment. These tools amalgamate pertinent clinical information drawn from a variety of sources. A perfect example is from August 2023, when US-based multinational medical technology firm GE HealthCare unveiled CardioVisio. This patient-focused clinical decision support tool aids physicians in implementing evidence-based clinical decision support, following current atrial fibrillation protocols, and visualizing longitudinal data from various data sources crucial to illness progression. CardioVisio, specifically geared for atrial fibrillation, allows cardiologists to refine their image interpretation practices and provide a comprehensive overview of the patient’s heart condition along with their health progress, inclusive of past diagnoses, prescribed medication, interventions, and co-existing health conditions.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

What Are the Key Regional Markets in the Atrial Fibrillation Industry?

North America was the largest region in the atrial fibrillation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8007

This Report Delivers Insight On:

1. How big is the atrial fibrillation market, and how is it changing globally?

2. Who are the major companies in the atrial fibrillation market, and how are they performing?

3. What are the key opportunities and risks in the atrial fibrillation market right now?

4. Which products or customer segments are growing the most in the atrial fibrillation market?

5. What factors are helping or slowing down the growth of the atrial fibrillation market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Atrial Fibrillation Market?

The uptick in the elderly population is projected to propel the atrial fibrillation market. Elderly people, defined as those aged 65 and above, are at a higher risk of falling due to factors such as postural hypotension and issues with balance or gait. Age and conduction disturbances are common causes of AF in this demographic, often identified in electrocardiograms prior to AF onset. As an example, the World Health Organization, a Swiss-based UN agency dealing with global public health, stated in October 2022 that by 2030, there will be six in every ten people aged 60 years or older. It is projected that there will be a jump from 1 billion in 2020 to 1.4 billion people by 2030 who are 60 years or older. The global population of people aged 60 and over is expected to double to 2.1 billion by 2050. From 2020 to 2050, there will be an additional 426 million people who are 80 years or older. Thus, the expanding elderly population is fuelling the progression of the atrial fibrillation market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

#How Does the ProjectedAtrial Fibrillation Market Growth Compare Over the Forecast Period?

The market size of atrial fibrillation has seen a swift expansion in the recent past. The market is anticipated to escalate from $13.56 billion in 2024 to $15.14 billion in 2025, marking a compound annual growth rate (CAGR) of 11.7%. Factors like heightened awareness and screening initiatives, advances in treatment technology, a surge in health expenditure, clinical studies and progression in drug creation, along with genetic vulnerability, have contributed to the growth during the historic period.

In the forthcoming years, a swift expansion is projected for the atrial fibrillation market, with a prediction to touch $24.93 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 13.3%. The anticipated growth within this period can be tied to several factors including stroke prevention efforts, education programs for patients and physicians, global cardiovascular health efforts, increase in electrophysiology procedures, personalized treatment plans, and governmental initiatives against cardiovascular diseases. The forecast period is also expected to witness some key trends such as diagnostic tech advancements, spike in atrial fibrillation occurrences, progressive catheter ablation methods, emergence of new oral anticoagulants (NOACs), incorporation of wearable tech in monitoring, the growing significance of telemedicine in AF management, and progress in implantable devices.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8007

What Are the Most Significant Market Trends Transforming theAtrial Fibrillation Market?

Leading businesses in the atrial fibrillation market are introducing cutting-edge products and services including patient-centric clinical decision support assists to solidify their presence in the industry. Clinical decision support systems (CDSS) are either software or electronic platforms developed to help health professionals make well-informed and prompt decisions on patient care. These systems are designed to incorporate relevant clinical data from various sources. For example, in August 2023, US-based multinational medical technology firm, GE HealthCare, launched CardioVisio, a patient-focused clinical decision support assist designed to aid physicians in making evidence-based clinical decisions influenced by current atrial fibrillation guidelines and visualize longitudinal data from numerous sources relevant to disease progression. CardioVisio for atrial fibrillation, is created to help cardiologists streamline image interpretation and offer a comprehensive view of the patient’s heart history and their healthcare journey, encompassing prior diagnoses, prescribed drugs, interventions, and concurrent diseases.

What Are the Top Market Players Propelling the Growth of theAtrial Fibrillation Industry?

Major companies operating in the atrial fibrillation market are AtriCure Inc., Johnson & Johnson Private Limited, Abbott Laboratories, C.H. Boehringer Sohn AG & Co. KG, Biotronik Se & Co. Kg, Boston Scientific Corporation, Bristol-Myers Squibb Company, CardioFocus Inc., Sanofi S.A, Medtronic PLC, Biosense Webster Inc., MicroPort Scientific Corporation, Siemens AG, Acutus Medical Inc., AEGEA Medical Inc., Apama Medical Inc., Aria CV Inc., Armetheon Inc., BioSig Technologies Inc., Cardialen Inc., CardioRobotics Inc., CardioInsight Technologies Inc., Circa Scientific LLC, CorWave SA, EpiEP Inc., Farapulse Inc., Fibralign Corporation, Impulse Dynamics NV, JenaValve Technology Inc., Kardium Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

Which Primary Segments of the Atrial Fibrillation Market Are Driving Growth and Industry Transformations?

The atrial fibrillation market covered in this report is segmented –

1) By Type: Surgical, Non-Surgical

2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies

3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion

4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Subsegments:

1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures

2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures, Device Implants

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=8007&type=smpGlobal Atrial Fibrillation Market, Global Atrial Fibrillation Market Report, Global Atrial Fibrillation Market Trends, Global Atrial Fibrillation Market Size

Browse Through More Reports Similar to the Gobal Atrial Fibrillation Maret 2025, By The Business Research Company:

Cardiovascular Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Cardiac Pacemakers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the atrial fibrillation market?

In recent years, there has been a swift expansion in the size of the atrial fibrillation market. It is projected to escalate from $13.56 billion in 2024 to $15.14 billion in 2025, with a compound annual growth rate (CAGR) of 11.7%. This growth within the historic period is due to several factors such as heightened awareness and screening initiatives, technological advances in treatment procedures, elevated healthcare spending, ongoing clinical research and drug development, and genetic predisposition.

What will be the atrial fibrillation market size in the future?

The market size of atrial fibrillation is predicted to experience swift expansion in the upcoming years. The growth will see the market worth $24.93 billion in 2029, with a compound annual growth rate (CAGR) of 13.3%. The surge during the projection period can be attributed to factors like increased attention towards stroke prevention, comprehensive patient and physician education programs, worldwide efforts to improve cardiovascular health, rise in electrophysiology procedures, customization in treatment plans, and government-led initiatives aimed at preventing cardiovascular diseases. Noteworthy trends in the forecast period include progress in diagnostic technologies, an increase in instances of atrial fibrillation, innovations in catheter ablation techniques, the advent of novel oral anticoagulants (NOACs), the integration of wearable technologies for monitoring purposes, a widening role of telemedicine in managing AF, and enhancements in implantable devices.

Get your atrial fibrillation market report here!

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

What main drivers are fueling expansion in the atrial fibrillation market?

The anticipated rise in the elderly community is set to propel the atrial fibrillation market. This refers to persons aged 65 and above, who due to several factors such as postural hypotension and issues with balance and gait, are at a higher risk of falling. The age factor and conduction abnormalities can often be observed on the surface electrocardiogram before the commencement of atrial fibrillation (AF) in the majority of elderly patients. For example, as per the World Health Organization, a Switzerland-based specialized wing of the United Nations that deals with international public health, they forecast that by 2030, six people globally will be 60 years of age or older. Notably, there will be an upsurge from 1 billion in 2020 to 1.4 billion people aged 60 or older. By 2050, the global count of individuals 60 or older will double to 2.1 billion, with an additional 426 million people aged 80 or more compared to current figures. Consequently, the expanding geriatric crowd is acting as a catalyst for the atrial fibrillation market growth.

What key areas define the segmentation of the global atrial fibrillation market?

The atrial fibrillation market covered in this report is segmented –

1) By Type: Surgical, Non-Surgical

2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies

3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion

4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Subsegments:

1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures

2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures, Device Implants

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

Who are the dominant players expanding their reach in the atrial fibrillation market?

Major companies operating in the atrial fibrillation market are AtriCure Inc., Johnson & Johnson Private Limited, Abbott Laboratories, C.H. Boehringer Sohn AG & Co. KG, Biotronik Se & Co. Kg, Boston Scientific Corporation, Bristol-Myers Squibb Company, CardioFocus Inc., Sanofi S.A, Medtronic PLC, Biosense Webster Inc., MicroPort Scientific Corporation, Siemens AG, Acutus Medical Inc., AEGEA Medical Inc., Apama Medical Inc., Aria CV Inc., Armetheon Inc., BioSig Technologies Inc., Cardialen Inc., CardioRobotics Inc., CardioInsight Technologies Inc., Circa Scientific LLC, CorWave SA, EpiEP Inc., Farapulse Inc., Fibralign Corporation, Impulse Dynamics NV, JenaValve Technology Inc., Kardium Inc.

How are evolving market trends shaping atrial fibrillation Strategies?

Top firms in the atrial fibrillation market are introducing innovative products and solutions, like patient-focused clinical decision support systems, to fortify their market presence. These clinical decision support tools (CDST) are either software or electronic systems aimed at helping healthcare professionals make informed and timely patient care decisions. Such tools are designed to consolidate pertinent clinical data from diverse sources. For example, in August 2023, GE HealthCare, a medical technology firm based in the U.S., unveiled CardioVisio, a patient-centric CDST. It supports physicians by providing evidence-based clinical decision assistance based on current atrial fibrillation guidelines and allows visualization of longitudinal data from various sources pertinent to disease progression. CardioVisio helps cardiologists streamline image interpretation and provides an overview of the patient’s cardiac history and healthcare journey, including prior diagnoses, medication, interventions, and accompanying health conditions.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8007

Which regions are emerging as leaders in the atrial fibrillation market?

North America was the largest region in the atrial fibrillation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cardiovascular Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Cardiac Pacemakers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

What are the Key Projections for the CAGR of the Atrial Fibrillation Market From 2025 to 2034?
The atrial fibrillation market size has grown rapidly in recent years. It will grow from $13.56 billion in 2024 to $15.14 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increasing awareness and screening programs, technological innovations in treatment, increasing healthcare expenditure, clinical research and drug development, genetic predisposition.

The atrial fibrillation market size is expected to see rapid growth in the next few years. It will grow to $24.93 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to focus on stroke prevention, patient and physician education programs, global initiatives for cardiovascular health, increasing electrophysiology procedures, customization of treatment plans, government initiatives for cardiovascular disease prevention. Major trends in the forecast period include advancements in diagnostic technologies, rise in the incidence of atrial fibrillation, advancements in catheter ablation techniques, emergence of novel oral anticoagulants (NOACs), integration of wearable technologies for monitoring, expanding role of telemedicine in AF management, advancements in implantable devices.

What Strategic Factors Are Influencing the Accelerated Growth of the atrial fibrillation Market?
The increase in the geriatric population is expected to drive the atrial fibrillation market forward. The geriatric population refers to adults 65 and older who are more likely to fall due to various factors, such as postural hypotension and balance or gait problems. Age factor and conduction disturbances are present on the surface electrocardiogram before AF onset in most geriatric patients. For instance, in October 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, six people in the world will be aged 60 years or older by 2030. At this point, there will be 1.4 billion people, up from 1 billion in 2020, who are 60 years of age or older. The number of individuals 60 and older in the world will double (to 2.1 billion) by the year 2050. Between 2020 and 2050, there will be 426 million more people who are 80 years of age or older than there are today. Therefore, the growing geriatric population is driving the growth of the atrial fibrillation market.

Request Your Free Atrial Fibrillation Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

What Are the Key Industry Players Leading the Charge in the Atrial Fibrillation Market’s Growth?
Major companies operating in the atrial fibrillation market are:
• AtriCure Inc.
• Johnson & Johnson Private Limited
• Abbott Laboratories
• C.H. Boehringer Sohn AG & Co. KG
• Biotronik Se & Co. Kg

How Are Market Trends and Shifts Impacting the Growth Trajectory of the Atrial Fibrillation Market?
Major companies in the atrial fibrillation market are launching innovative products and solutions such as patient-centric clinical decision support tools to strengthen their position in the market. Clinical decision support tools (CDST) are software or electronic systems designed to assist healthcare professionals in making informed and timely decisions about patient care. These tools are developed to integrate relevant clinical information from various sources. For instance, in August 2023, GE HealthCare, a US-based multinational medical technology company launched the CardioVisio, a patient-centered clinical decision support tool to help doctors drive evidence-based clinical decision support guided by current atrial fibrillation guidelines and visualize longitudinal data from various data sources relevant for illness progression. CardioVisio for atrial fibrillation, can assist cardiologists with in streamlining clinician image interpretation and to provide a view of the history of the patient’s heart as well as their healthcare journey, including previous diagnoses, prescribed medications, interventions, and comorbidities.

Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

Which Key Segments Define the Structure of the Atrial Fibrillation Market and Their Growth Potential?
The atrial fibrillation market covered in this report is segmented –

1) By Type: Surgical, Non-Surgical
2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies
3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion
4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Subsegments:
1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures
2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures, Device Implants

What Regions Are Influencing the Dynamics of the Atrial Fibrillation Market?
North America was the largest region in the atrial fibrillation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Scope and Reach of the Atrial Fibrillation Market Defined?
Atrial fibrillation refers to a disorder of the heart caused by an abnormality in the normal sequence of electrical impulses that changes the rate or rhythm at which the heart beats and begins in the heart’s upper chambers (atria). Electrical impulses can be too fast, too slow, or erratically occurring, resulting in irregular heartbeats.

Browse Through More Similar Reports By The Business Research Company:

Cardiovascular Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Cardiac Pacemakers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:”